Berenson Stephen
SEC insider (Form 3/4/5 filer). CIK 0001760671. Director at Seres Therapeutics, Inc. (MCRB). 4 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in CAMBRIDGE, MA.
Companies Berenson Stephen has filed insider reports for
- Seres Therapeutics, Inc. (MCRB): Director
Berenson Stephen
CIK: 0001760671
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Seres Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 8, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
6.5K shares- - Jul 1, 2026MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.5K shares- - Jul 1, 2025MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
11.5K shares- - Apr 10, 2025MCRB
Seres Therapeutics, Inc.
AwardDirectStock Option (right to buy)
100K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 8, 2026 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 6,500 | - | - | Direct |
| Jul 1, 2026 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 7,508 | - | - | Direct |
| Jul 1, 2025 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 11,470 | - | - | Direct |
| Apr 10, 2025 | MCRB Seres Therapeutics, Inc. | Award Stock Option (right to buy) | 100,000 | - | - | Direct |
1-4 of 4 transactions